Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
TIlray Brands, Inc. (TLRY) generates frequent news as a global lifestyle and consumer packaged goods company active across cannabis, beverage, wellness, and entertainment categories. Company updates often highlight developments in its cannabis brands, medical cannabis operations, beverage portfolio, and strategic corporate actions, giving investors and followers insight into how Tilray is executing its multi-category strategy.
News coverage commonly includes financial results and segment performance across cannabis, beverage, wellness, and distribution, as reflected in Tilray’s quarterly earnings releases. These updates may discuss trends in international medical cannabis revenue, Canadian adult-use cannabis sales, and distribution activity through Tilray Pharma. Corporate announcements, such as the implementation of a one-for-ten reverse stock split and related shareholder decisions, are also reported through press releases and SEC filings.
Tilray’s brand and product news provides detail on new launches and category expansion. Recent communications feature Dry January and holiday guides showcasing hemp-derived THC beverages, zero-proof spirits, non-alcoholic beers, and craft beers, as well as cannabis-infused beverages under brands like Mollo and XMG. Other releases focus on innovations in cannabis vapes and concentrates under brands such as Good Supply and Redecan, and curated cannabis gift guides that reflect consumer trends in Canada.
Regulatory and medical developments are another important theme. Tilray Medical has issued statements on U.S. federal cannabis rescheduling and the creation of Tilray Medical USA, outlining a framework for U.S. medical cannabis expansion based on experience in regulated international markets. For readers tracking TLRY, this news stream offers context on how the company responds to policy changes, evolves its brand portfolio, and communicates with shareholders. Bookmark this page to access an organized feed of Tilray’s earnings releases, product announcements, regulatory updates, and other material company news.
Tilray Brands (TLRY) reported strong Q2 2025 financial results with notable growth across all business segments. Net revenue increased 9% year-over-year to $211 million, while gross profit rose 29% to $61 million. The company's beverage segment showed remarkable performance with a 36% revenue increase to $63 million.
The company reported a net loss of $(85) million, of which $75 million was comprised of non-cash items. Adjusted EBITDA was $9 million compared to $10 million in the prior year. Tilray announced Project 420, a $25 million synergy plan for its beverage business, with $17 million already achieved by Q2 end.
Key segment performance includes beverage alcohol gross margin increasing to 40%, cannabis net revenue at $66 million with 35% gross margin, distribution revenue of $68 million, and wellness segment growing 13% to $15 million. The company reaffirmed its fiscal year 2025 guidance of anticipated net revenues between $950 million and $1 billion.
Tilray Medical, through its German subsidiary Tilray Deutschland GmbH, has won a tender from Luxembourg's Ministry of Health and Social Security to supply medical cannabis flower to the country. This achievement reinforces Tilray's position in Europe's growing medical cannabis market and demonstrates the company's capability to consistently deliver high-quality medical cannabis products internationally.
According to Denise Faltischek, Chief Strategy Officer and Head of International, this repeat selection by Luxembourg validates the company's commitment to providing quality medical cannabis to patients worldwide.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) has rescheduled its second quarter fiscal 2024 earnings release from January 9 to January 10, 2025, before market open. The change is due to the closure of the SEC and U.S. stock markets on January 9 for the National Day of Mourning honoring former President Jimmy Carter.
The company will host a live conference call and audio webcast to discuss the results at 8:30 am Eastern Time on January 10. The financial results will cover the quarter ended November 30, 2024. Investors can access the webcast through Tilray's website investor section.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) has announced its expanded cannabis beverage portfolio in Canada, featuring products under three brands: Mollo, Solei, and XMG. The lineup includes various THC, CBD, and CBG-infused beverages with different cannabinoid concentrations and flavors.
Mollo Seltzers offers Blackberry flavor (10mg THC, 20mg CBG) with upcoming Wildberry Acai and Watermelon Lime variants. Solei's range includes sparkling beverages and cold brew teas with varying THC/CBD/CBG combinations. XMG features two product lines: XMG+ with caffeine-infused options and XMG Zero with zero-calorie sodas containing 10mg THC.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) introduces its non-alcoholic beverage portfolio for the new year, featuring multiple brands. Liquid Love offers sparkling waters with electrolytes and B-vitamins in four flavors, donating five cents per sale to water conservation. Herb & Bloom and Happy Flower both feature hemp-derived Delta-9 THC (5mg per can) in various mocktail flavors. Runner's High presents alcohol-free craft brews in Golden Wheat, Raspberry Wheat, and Dark Chocolate varieties. Montauk Brewing Company debuts its first N.A. IPA with less than 0.5% ABV, featuring Citra, Mosaic, and Cryo hops.
SweetWater Brewing Company, the Southeast's largest craft brewer and a Tilray Brands (NASDAQ: TLRY) subsidiary, announces its 28th Anniversary Bash featuring electronic jam band STS9 as headliner. The event is scheduled for February 22 at SweetWater's Atlanta brewery.
The celebration includes double sets by STS9, performances by Break Science, Marvel Years, Sneezy, and others, plus a Rock Poster Show featuring authentic band posters. Early Bird General Admission tickets are priced at $60, while KUSH VIP tickets cost $97, offering additional perks including complimentary drinks, VIP access, and exclusive viewing areas.
SweetWater's HoliBlaze promotion offers 25% off when purchasing Anniversary Party tickets together with SweetWater 420 Fest weekend passes, available until January 1.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, has announced it will release its second quarter fiscal 2025 financial results on January 9, 2025, before market open. The results will cover the period ended November 30, 2024. The company will host a live conference call and audio webcast at 8:30 a.m. Eastern Time to discuss the results, which will be accessible through the Investors section of Tilray's website.
Redecan Cannabis, a Tilray Brands (TLRY) brand, has expanded its 'Wrapped & Redee' Redees Hemp'd line with two new -edition genetics for the holiday season. The new offerings include Legendary Kush (Sativa) and Orange Cream Fuel (Indica), available in 20 x 0.4g packs containing ten pre-rolls of each strain.
The pre-rolls feature ultra-thin hemp paper and patented filter tips, made with hang-dried and precisely milled flower. Legendary Kush combines Larry OG and Legend OG genetics, offering earthy, citrus, and spicy notes. Orange Cream Fuel, derived from Jet Fuel Gelato and Orange Cookies, provides fruity and diesel undertones. Both products are available nationwide at authorized Canadian cannabis retailers.
Tilray Brands (Nasdaq: TLRY; TSX: TLRY) announced new product launches under its Good Supply cannabis brand for the holiday season. The lineup includes three major innovations: JUICED XTREME Resin Infused Pre-rolls featuring double infusion of full spectrum resin and naturally flavoured distillate in 0.6g cones; 2g 510 Vapes with double-distilled THC distillate and unique cannabinoid blend (1,000mg THC, 300mg CBG, 300mg CBD); and Monsters: 'The Grump' Holiday -Edition Pre-rolls containing 1,000mg THC in 2.38g of infused pre-rolls. Products will be available at select Canadian retailers with planned national expansion in the new year.
Tilray Brands (NASDAQ: TLRY; TSX: TLRY) has launched Herb & Bloom, a new line of non-alcoholic, hemp-derived Delta-9 THC beverages. The initial product range features three cocktail-inspired flavors: Margarita, Strawberry Daiquiri, and Peach Bellini, each containing 5mg of natural hemp-derived Delta-9 THC. The brand features Art Deco design elements and focuses on sophisticated, refreshing fruit flavors.
The company plans to expand the product line with 10mg options in select markets later in the season. The beverages are designed to offer a premium non-alcoholic alternative with carefully balanced flavor profiles and suggested garnishing options for enhanced presentation.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
